View speakers, slides, and presentations from previous year's symposiums.
8th Symposium on General Population Screening for T1D
November 10-11, 2025
Barbara Davis Center for Diabetes
Target Audience: Healthcare professionals including MD, DO, advanced practice providers, nurses, social workers, and dieticians; researchers in the area of screening, monitoring, and prevention of diabetes; lay representatives of patient organizations and representatives of funding agencies.
Learning Objectives:
1) Review the latest consensus guidelines and global evidence supporting early detection and screening for stage 1 and 2 type 1 diabetes (T1D) in the general population.
2) Explain advancements in islet autoantibody screening methods, including laboratory techniques and strategies for staging and risk stratification.
3) Explain best practices for confirming positive screening results and communicating findings to families and patients.
4) Discuss emerging interventions, clinical trials, and implementation strategies aimed at delaying or preventing progression to symptomatic T1D.
5) Collaborate with interdisciplinary teams to address challenges in screening implementation, patient monitoring, and integration into clinical workflows across healthcare systems.
*Open to all Anschutz Medical Campus faculty and staff.
The University of 麻豆传媒高清 School of Medicine designates this live activity for a maximum of 13.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.